Focal nodular hyperplasia after oxaliplatin-based chemotherapy: A diagnostic challenge.

Focal nodular hyperplasia Gadoxetic acid Liver Magnetic resonance imaging Metastases Oxaliplatin

Journal

Radiology case reports
ISSN: 1930-0433
Titre abrégé: Radiol Case Rep
Pays: Netherlands
ID NLM: 101467888

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 18 10 2021
revised: 28 02 2022
accepted: 02 03 2022
entrez: 11 4 2022
pubmed: 12 4 2022
medline: 12 4 2022
Statut: epublish

Résumé

Chemotherapy could induce benign liver alterations presenting as diffuse or focal lesions mimicking metastases. Oxaliplatin-induced vascular liver injury is described in literature, but the association with FNH-like lesions has been reported in a limited number of cases. We herewith describe the case of a 67-year-old male, who had laparoscopic right-sided hemicolectomy, 8 years ago, because of colonic adenocarcinoma (pT3N0M0) and subsequent adjuvant chemotherapy (capecitabine + oxaliplatin), who referred to the ultrasound service of our Radiology Unit because of abdominal pain. Five-years follow-up was negative for metastases. Ultrasound examination showed 2 small hypoechoic hepatic nodules, in segment VIII and VII, confirmed at CT, suspected for metastases. FDG-PET was negative, and blood tumor markers were within normal ranges. For further evaluation we performed gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI that showed hyperintensity of the nodules in the hepatobiliary phase with central small hypointensity due to a central scar. Considering the previous oxaliplatin-based chemotherapy the findings were compatible with FNHlike lesions and the diagnostic suspicion was confirmed at ultrasound-guided core needle biopsy. Knowledge of the possible occurrence of FNH-like lesions in oncologic setting, along with the detection of typical MRI appearance, is important for appropriate management and may avoid unnecessary biopsy or surgery and reduce patients' anxiety.

Identifiants

pubmed: 35401910
doi: 10.1016/j.radcr.2022.03.020
pii: S1930-0433(22)00185-6
pmc: PMC8990178
doi:

Types de publication

Case Reports

Langues

eng

Pagination

1858-1865

Informations de copyright

© 2022 The Authors. Published by Elsevier Inc. on behalf of University of Washington.

Références

Abdom Radiol (NY). 2016 Jan;41(1):25-32
pubmed: 26830608
J Hepatol. 2008 Jul;49(1):61-71
pubmed: 18466996
Radiology. 2015 Nov;277(2):413-23
pubmed: 26020440
Cancer. 2003 Jun 15;97(12):3107-13
pubmed: 12784348
Clin Imaging. 2012 Jul-Aug;36(4):301-7
pubmed: 22726968
J Gastrointest Surg. 2007 Apr;11(4):472-8
pubmed: 17436132
Abdom Radiol (NY). 2018 Sep;43(9):2321-2328
pubmed: 29427046
Radiology. 2014 May;271(2):416-25
pubmed: 24475862
Insights Imaging. 2021 Jan 12;12(1):8
pubmed: 33432491
AJR Am J Roentgenol. 2018 Apr;210(4):775-779
pubmed: 29323545
Eur Radiol. 2012 Apr;22(4):864-71
pubmed: 22108766
Am J Surg Pathol. 1999 Dec;23(12):1441-54
pubmed: 10584697
World J Hepatol. 2013 Jun 27;5(6):340-4
pubmed: 23805360
Eur Radiol. 2015 Apr;25(4):950-60
pubmed: 25537979
Radiol Bras. 2019 Sep-Oct;52(5):343-344
pubmed: 31656355
J Gastrointest Cancer. 2020 Jun;51(2):628-630
pubmed: 31494788
Surgeon. 2013 Feb;11(1):25-9
pubmed: 22738949
Insights Imaging. 2021 Jun 10;12(1):76
pubmed: 34114094
Case Rep Surg. 2021 Apr 3;2021:6676109
pubmed: 33880199
Invest Radiol. 2011 Apr;46(4):225-39
pubmed: 21102346
AJR Am J Roentgenol. 2012 Jul;199(1):186-91
pubmed: 22733911
Eur J Radiol. 2010 Jun;74(3):e1-5
pubmed: 19369017
Bone Marrow Transplant. 2015 Mar;50(3):414-9
pubmed: 25581411
Eur J Radiol. 2012 Dec;81(12):3877-82
pubmed: 22954410
Ann Hepatol. 2013 Mar-Apr;12(2):308-14
pubmed: 23396743
Histopathology. 2010 Mar;56(4):430-9
pubmed: 20459550
Gastroenterology. 2015 Nov;149(6):e1-3
pubmed: 26433107
Liver Int. 2009 Mar;29(3):459-65
pubmed: 18803590
Radiographics. 2016 Nov-Dec;36(7):2010-2027
pubmed: 27740898
Am J Surg Pathol. 2012 Nov;36(11):1691-9
pubmed: 23060349
Eur J Radiol. 2012 Dec;81(12):3998-4004
pubmed: 22921889

Auteurs

Lorenzo Vassallo (L)

Department of Radiology, S.S. Annunziata Hospital, ASLCN1, Via degli Ospedali 9, 12038 Savigliano, Cuneo, Italy.

Mirella Fasciano (M)

Department of Radiology, S.S. Annunziata Hospital, ASLCN1, Via degli Ospedali 9, 12038 Savigliano, Cuneo, Italy.

Mirella Fortunato (M)

Department of Pathology, Santa Croce e Carle Hospital, Via Michele Coppino 26, 12100, Cuneo, Italy.

Giulio Fraternali Orcioni (GF)

Department of Pathology, Santa Croce e Carle Hospital, Via Michele Coppino 26, 12100, Cuneo, Italy.

Tiziana Vavala' (T)

Department of Oncology, S.S. Annunziata Hospital, ASLCN1, Via degli Ospedali 9, 12038 Savigliano, Cuneo, Italy.

Daniele Regge (D)

Department of Radiology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.
University of Turin Medical School, Candiolo, Turin, Italy.

Classifications MeSH